In a subgroup of patients with thrombolysis in myocardial infarction flow 1 , nitrite reduced infarct size and major adverse cardiac event and improved myocardial salvage index , indicating that a phase III clinical trial assessing intracoronary nitrite administration as an adjunct to percutaneous coronary intervention in ST-elevated myocardial infarction patients is warranted .